Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director
PLAINSBORO, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Rhonda Germany Ballintyn to its board of directors, effective today.  Ms.
View HTML
Toggle Summary Integra LifeSciences Announces Agreement with Consortium of Focused Orthopedists to Develop a Short Stem and Stemless Shoulder System
PLAINSBORO, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq: IART ), a leading global medical technology company, today announced it has signed a license and development agreement with Consortium of Focused Orthopedists, LLC (CFO), for a short stem and
View HTML
Toggle Summary Integra LifeSciences Announces Preliminary Fourth Quarter 2018 Financial Results
Preliminary Fourth Quarter 2018 Highlights: Fourth quarter 2018 reported revenue is expected to be at the higher end of the company’s previous guidance range of $378 million to $383 million; Organic revenue growth in the fourth quarter 2018 is expected to be slightly above 4%.
View HTML
Toggle Summary Integra LifeSciences to Present at the 37th Annual J.P. Morgan Healthcare Conference
PLAINSBORO, N.J., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 37 th Annual J.P.
View HTML
Toggle Summary Integra® XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery
PLAINSBORO, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced one of the first surgeries with the Integra® XT Revision Total Ankle Replacement System.
View HTML
Toggle Summary Integra LifeSciences Appoints Eric Schwartz, Corporate Vice President, General Counsel and Secretary
PLAINSBORO, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the appointment of Eric Schwartz as corporate vice president, general counsel and secretary.   “I am pleased to welcome Eric as our new general counsel and latest member of
View HTML
Toggle Summary Integra LifeSciences to participate in Healthcare Conferences in November 2018
PLAINSBORO, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in October: On Thursday, November 15, 2018 at 9:10 a.m.
View HTML
Toggle Summary Integra LifeSciences Reports Third Quarter 2018 Financial Results
Revenue Increased 31.2% to $365.9 million; Organic Revenue Increased 6.2% Reported EPS of $0.15; Adjusted EPS of $0.59 Revises Full-Year 2018 Revenue Guidance to $1.467 Billion to $1.472 Billion and Organic Revenue Growth to Approximately 4% PLAINSBORO, N.J., Oct.
View HTML
Toggle Summary Integra LifeSciences to Host Third Quarter 2018 Earnings Results Conference Call on October 31, 2018
PLAINSBORO, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2018 financial results on Wednesday, October 31, 2018, prior to market open.
View HTML
Toggle Summary Integra LifeSciences to participate in the Cantor Global Healthcare Conference
PLAINSBORO, N.J., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in October: On Monday, October 1, 2018 at 4:05 p.m.
View HTML
Toggle Summary Integra LifeSciences Selected for Healogics iSupply℠ Program
PLAINSBORO, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has been selected as a primary provider for cellular-based tissue products within Healogics ® Inc. new iSupply program.
View HTML
Toggle Summary Integra LifeSciences to Present at Healthcare Conferences in September 2018
PLAINSBORO, N.J., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in September: On Thursday, September 6, 2018 at 8:35 a.m.
View HTML
Toggle Summary Integra LifeSciences Announces the Launch of its New CUSA® Clarity Ultrasonic Tissue Ablation Platform in Japan
Tokyo, Japan, July 23, 2018 - Integra LifeSciences Holdings Corporation (Nasdaq: IART ), a global leader in medical technology, announces the launch of its new CUSA ® Clarity ultrasonic tissue ablation platform in Japan. The system was launched in North America and Europe and has gained significant
View HTML
Toggle Summary Integra LifeSciences Reports Second Quarter 2018 Financial Results
Revenue Increased 29.8% to $366.2 million; Organic Revenue Increased 3.4%  Reported EPS of $0.14; Adjusted EPS of $0.60 Raises Low-End of Full-Year Total Revenue and EPS Guidance Successfully Exits First Wave of Codman Transition Services Agreements PLAINSBORO, N.J., July 25, 2018 (GLOBE NEWSWIRE)
View HTML
Toggle Summary Integra LifeSciences to Host Second Quarter 2018 Earnings Results Conference Call on July 25, 2018
PLAINSBORO, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release second quarter 2018 financial results on Wednesday, July 25, 2018, prior to market open.
View HTML